Sogroya (somapacitan)
pCPA File Number:
22502
Negotiation Status:
Negotiations were not pursued* (*No supply available in Canada.)
Indication(s):
Growth hormone deficiency
Sponsor/Manufacturer:
Novo Nordisk Canada Inc.
CDA-AMC Project Number:
SR0779-000
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded: